All Posts

Confusion persists on how DEA intends to regulate and enforce pharmacies’ delivery of patient-specific medication to physicians’ offices...

Last week, the Drug Enforcement Administration’s (“DEA”) last remaining administrative law judge (“ALJ”) retired, leaving DEA with no ALJ...

In February 2024, DEA announced it entered into a settlement agreement with Morris & Dickson Co., LLC (“Morris & Dickson”), resolving the...

On August 31, 2023, DEA published a final rule (“Final Rule”) regarding its management of controlled substance and List 1 Chemical (“L1...

Over the last decade, the increased use of Controlled Substance Ordering System (“CSOS”) applications (i.e., platforms used to...

On June 22, 2023, DEA published a final rule regarding the timing with which registrants are required to report the theft or loss of...

On May 26, 2023, the Drug Enforcement Administration (DEA) published a final decision and order (the “Final Order”) affirming an...

I On December 29, 2022, the Consolidated Appropriations Act of 2023 (Public Law No. 117-328) (the “Legislation”) was signed into law,...

Through an April 13, 2020 letter to registered practitioners, the Drug Enforcement Administration (DEA) announced that, effective January...

The US Drug Enforcement Administration (DEA) recently released its annual National Drug Threat Assessment. While highlighting challenges...